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Abstract 25 
 26 
Objective: Floating aortic thrombus is an under-recognised source of systemic emboli 27 and carries a life-threatening risk of stroke when located in the aortic arch. Optimal 28 treatment is not established in available guidelines. We report our experience in 29 managing floating thrombi in the aortic arch. 30  31 
Methods: Consecutive patients diagnosed with a floating aortic arch thrombus at a 32 tertiary referral centre between January 2008 and December 2014 were reviewed. 33 Perioperative and mid-term outcomes were assessed. 34  35 
Results: Ten patients (eight female) with a median age of 56 years (range 47-82 years) 36 were identified. Eight patients presented with a symptomatic embolic event while two 37 patients were asymptomatic. One patient presenting with stroke due to embolic 38 occlusion of all supra-aortic vessels died two days following admission. Three patients 39 (two asymptomatic and one unfit for surgery) were treated conservatively by 40 anticoagulation, leading to thrombus resolution in two patients. In the third patient, the 41 thrombus persisted despite anticoagulation, resulting in recurrent embolic events. 42 The remaining six patients underwent open thrombectomy of the aortic arch during 43 deep hypothermic circulatory arrest. All patients treated by surgery had an uneventful 44 postoperative course with no recurrent thrombus or embolic event during follow-up. 45 Median follow-up of all patients was 17 months (range 11 - 89 months).  46 
 3 
Conclusions: Floating aortic arch thrombus is a dangerous source of systemic emboli. 47 Surgical removal of the thrombus is easy to perform and followed by very good clinical 48 results. Conservative treatment with anticoagulation may be considered in 49 asymptomatic, inoperable or very high-risk patients. 50  51 Abstract word count: 246  52 
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Central Message 53 Floating aortic arch thrombus is a dangerous source of emboli. Surgical removal of the 54 thrombus is easy to perform and followed by very good clinical results.  55 
 5 
Perspective Statement 56 Optimal treatment of floating aortic arch thrombus is not well established. Evidence 57 concerning aortic arch thrombectomy for floating thrombi is scarce. With this study, we 58 add a series of patients to the literature and demonstrate that aortic arch thrombectomy 59 can be performed easily and with very good clinical results in terms of prevention of 60 further embolic events in these patients.  61 
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Abbreviations and Acronyms 62 AC = Anticoagulation 63 ASA = Acetylsalicylic acid 64 CT = Computed tomography 65 DHCA = Deep hypothermic circulatory arrest 66 DL = Dyslipidaemia 67 DM = Diabetes mellitus 68 DVT = Deep venous thrombosis 69 HT = Hypertension 70 LMWH = Low molecular weight heparin 71 MRI = Magnetic resonance imaging 72 NIHSS = National Institutes of Health Stroke Scale 73 PAD = Peripheral artery disease 74 TEE = Transesophageal echocardiography 75 TIA = Transient ischaemic attack  76 
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Introduction 77 Floating aortic thrombus is rare, but with the more frequent use of imaging modalities 78 over the past decades, it has increasingly been identified as a source of systemic emboli 79 (1). In a study of 10’671 consecutive autopsies, the incidence of aortic mural thrombus 80 was 0.45 % (2). The most common location reported in clinical studies (3) is the 81 descending thoracic aorta and the aortic arch. Detailed pathophysiological mechanisms 82 are not yet fully understood. Some authors reported mobile thrombi on aortic arch 83 atheroma in predominantly elderly patients with atherosclerotic disease (4). Floating 84 aortic thrombus however, is often seen in relatively young patients without severe 85 atherosclerosis and many authors agree, that it is a distinct clinical entity that has to be 86 distinguished from atheromatous debris (1, 3, 5), although atherosclerotic processes 87 may contribute to its pathogenesis (1). A high prevalence of haematological disorders 88 and other hypercoagulable conditions, like malignancy, has been reported in other 89 series, suggesting these may also be causative factors for thrombus formation (3). 90 Treatment options include anticoagulation (6, 7), surgical thrombectomy (8-10) and in 91 some cases, endovascular treatment (11, 12). However, comparative data is scarce and 92 available guidelines (13) lack treatment recommendations. 93 Thrombus localisation in the aortic arch is particularly challenging, as cerebral 94 embolisation is an impending risk with substantial morbidity and mortality. Surgical 95 treatment of aortic arch thrombus requires extracorporeal circulation and circulatory 96 arrest. It is unclear, whether the benefits of open thrombus removal outweigh the 97 perioperative risks of aortic arch surgery. For aortic arch atheroma (with or without 98 mobile components), current stroke guidelines do not recommend surgical treatment to 99 prevent cerebral embolisation (14). This is based on a study by Stern et al. who analysed 100 stroke risk during cardiac surgery in patients with arch atheroma and reported an 101 
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unproportionally high incidence of intraoperative stroke (34.9 %) in patients who 102 underwent arch endarterectomy in addition to another cardiac procedure (15). 103 The aim of this study was to assess detailed narrative data including risk factors, clinical 104 presentation, treatment modality and mid-term outcome of patients with floating aortic 105 arch thrombus. Our hypothesis was that surgical management has a favourable outcome 106 and effectively prevents further embolic events in patients with floating aortic arch 107 thrombus. 108  109 
Materials and Methods 110 Consecutive patients treated for floating aortic arch thrombus at a Swiss tertiary referral 111 centre (University Hospital Bern) between January 2008 and December 2014, were 112 identified. Individual patient consent was obtained and the study was performed 113 according to the requirements of the local ethics committee. 114 Floating aortic arch thrombus was defined as a homogenous mass on computed 115 tomography (CT) or transesophageal echocardiography (TEE) images, attached to the 116 aortic wall and protruding into the lumen of the aortic arch with a mobile aspect (Figure 117 1). Information on size, exact localisation and quality of the attachment site of the 118 thrombus was retrieved from contrast-enhanced CT scans (1 mm slice thickness). Data 119 including patient demographics, cardiovascular and thrombotic risk factors, 120 embolisation site, treatment method and postoperative complications, were collected 121 from hospital records. Patient follow-up included regular visits in our outpatient clinic 122 and was completed by a telephone interview of all patients or their general practitioner 123 at the end of June 2015 to assess for death, recurrent embolism, continuation of 124 anticoagulation, and subsequently diagnosed malignant disease.  125 
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Results 126 
Patient characteristics and clinical presentation 127 Over a period of seven years, a total of 10 patients were identified. Eight patients were 128 female and median age was 56 years (range 47 – 82 years). All patients had two or more 129 cardiovascular risk factors, mainly hypertension (n = 8), smoking (n = 7) or a body mass 130 index ≥ 30 kg/m2 (n = 7). Other previously described predisposing factors for aortic 131 thrombus formation (7) were: steroids (n = 2), hormone replacement therapy (n = 1) 132 and malignancy (n = 1, high-grade undifferentiated pleomorphic sarcoma of the pelvic 133 bone). Two patients had either a personal or a family history of venous 134 thromboembolism. Thrombophilia testing was performed in six patients and revealed 135 procoagulant abnormalities in four (Table 1). One patient had a patent foramen ovale. 136 None had atrial fibrillation or any other identifiable embolic source. The diameter of the 137 ascending aorta and aortic arch was normal in all patients. Thrombus developed under 138 combined acetylsalicylic acid (ASA) and statin treatment in two patients (# 2 and 7), 139 under ASA in two patients (# 9 and 10) and under statin therapy in one patient (# 6). No 140 patients were on anticoagulation therapy at presentation. 141 Eight patients were diagnosed with floating aortic arch thrombus after a symptomatic 142 embolic event including upper or lower limb ischaemia (n = 4), distal aortic occlusion (n 143 = 1), visceral ischaemia (n = 1), and ischaemic stroke (n = 2) (Table 2). Of these patients, 144 six were diagnosed by CT angiography while two were initially diagnosed by TEE. One 145 patient (# 5) had two TEE examinations that did not demonstrate the thrombus, before 146 it was diagnosed by CT angiography. 147 Two patients had no symptomatic embolic event at presentation (# 4 and 9). The 148 thrombus was incidentally diagnosed by CT, performed for acute chest pain or cancer 149 staging.  150 
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Thrombus localisation and morphology 151 Three patients (# 2, 8 and 9) had two thrombi localised in the aortic arch, resulting in a 152 total of 13 thrombi in 10 patients. Median thrombus length measured on CT scans was 153 2.8 cm (range 1.3 – 4.3 cm) and median width was 0.9 cm (range 0.5 – 1.8 cm). No 154 correlation between thrombus size and symptoms was observed. 155 The localisation of the attachment sites is displayed in Figure 2. On CT scans, the 156 attachment site appeared to be normal aortic wall in six patients, whereas in three 157 patients, there were minor calcified atherosclerotic changes. Only patient # 6 showed 158 evidence of a heavily calcified plaque at the attachment site. 159  160 
Treatment 161 In six patients (# 1, 2, 3, 6, 7, 8) surgical embolectomy was required to treat the initial 162 embolic event. Histological examination of the embolus was performed in five patients 163 and confirmed thrombus. Endovascular cerebral mechanical thrombectomy was 164 performed in two patients with ischaemic stroke (# 5 and 10). Patient # 10, presenting 165 with stroke due to embolic occlusion of all supra-aortic vessels, died two days following 166 unsuccessful mechanical thrombectomy. For these two patients, no analysis of the 167 removed embolic material was available. 168 In three patients, the floating aortic arch thrombus was treated conservatively using 169 anticoagulation only, including one symptomatic patient aged 77 years (# 6) who was 170 considered unfit for aortic arch surgery and two asymptomatic patients (# 4 and 9). The 171 remaining six patients were scheduled for open aortic arch thrombectomy.  172 
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Aortic arch thrombectomy 173 Aortic arch thrombectomy was performed via median sternotomy using 174 cardiopulmonary bypass and deep hypothermic circulatory arrest (DHCA). Arterial 175 cannulation site for cardiopulmonary bypass was the right subclavian artery (n = 4) or 176 the ascending aorta (n = 2), depending on thrombus localisation. Median operating time 177 was 180 minutes (range 120 – 277 minutes) and median DHCA duration was 17 minutes 178 (range 12 – 42 minutes) with antegrade cerebral perfusion (median 16 minutes, range 179 11-42 minutes). In one patient with very short DHCA (12 minutes), antegrade cerebral 180 perfusion was not performed. During opening, preparation for cardiopulmonary bypass 181 and cannulation, the thrombus was monitored by TEE. After incision of the aortic arch, 182 the thrombus was completely removed in all patients (Figure 3). The aortic wall at the 183 attachment site was resected in four patients (full thickness wall resection), whereas the 184 aortic wall seemed macroscopically normal in two patients. Aortotomy as well as the 185 resection site in case of attachment site resection was directly closed by double layer 4-0 186 polypropylene running sutures in all patients. No prosthetic material was used, neither 187 as a vascular graft nor as a patch. 188 Histological examination confirmed that the removed material was a thrombus in all 189 patients. Microscopically, the attachment site was unremarkable in one patient while 190 showing a cholesterol-rich plaque in three patients. 191  192 
Follow-up 193 Median follow-up was 17 months (range 11 – 89 months). At the end of follow-up, eight 194 out of ten patients were alive. Patient # 10 died in the context of the initial embolic 195 event and patient # 9 died 11 months after diagnosis of the aortic arch thrombus due to 196 
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the underlying malignant disease. In all other patients, no malignant disease as a 197 potential causative factor for thrombus formation was diagnosed during follow-up. 198  199 
Conservative treatment: 200 In patient # 4, asymptomatic at presentation, follow-up CT confirmed complete 201 resolution of the thrombus, leading to discontinuation of oral anticoagulation after three 202 months. Seven months later, the patient presented with embolic occlusion of the 203 forearm arteries, requiring embolectomy. Histological examination of the removed 204 material confirmed thrombus, but no recurrent thrombus in the aortic arch or other 205 embolic source could be identified. Under resumed anticoagulation, the patient 206 experienced no further embolic events. 207 The elderly, symptomatic patient (# 6), considered unfit for open aortic arch surgery, 208 had complete resolution of the thrombus after three months (follow-up CT) and no 209 recurrent embolism under continued anticoagulation at the end of follow-up. 210 The patient with malignant sarcoma (# 9), asymptomatic at diagnosis of the aortic arch 211 thrombus, suffered from ischaemic stroke two days following initiation of 212 anticoagulation and underwent intravenous thrombolytic therapy. Thrombus formation 213 in the aortic arch remained unchanged on follow-up CT scans. Due to progressive 214 malignant disease, this patient was not considered a candidate for surgical 215 thrombectomy. Despite continued anticoagulation (low molecular weight heparin), the 216 patient suffered from multiple transient ischaemic attacks and died 11 months later as a 217 consequence of his malignancy.  218 
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Surgical treatment: 219 All six patients treated by open aortic arch thrombectomy had an uneventful 220 postoperative course. No ischaemic stroke, myocardial infarction, significant 221 deterioration of renal function, postoperative haemorrhage or sternal infection was 222 documented. Postoperatively, five patients received oral anticoagulation treatment with 223 coumarin. Patient # 5, initially presenting with stroke, received no anticoagulation due 224 to haemorrhagic transformation of the cerebral infarction. Patient # 3 was prescribed 225 dual antiplatelet therapy (ASA and clopidogrel) at discharge because therapeutic 226 anticoagulation doses could not be established with coumarin. Patient # 2 was switched 227 from coumarin to clopidogrel 28 months after surgery. Three patients were still on 228 coumarin at the end of follow-up. There were no recurrent embolic events or recurrent 229 aortic thrombi in these surgically treated patients. 230  231 
Discussion 232 In this study, we present a consecutive series of ten patients with floating thrombus in 233 the aortic arch, six of whom were treated by open aortic arch thrombectomy. Median 234 age of our patients was slightly higher than reported in other series (1, 3, 16). Female 235 predominance has been reported before (5, 17). Mild procoagulant abnormalities were 236 present in 40 % of patients and in one patient, the aetiology of the thrombus was most 237 likely paraneoplastic, but overall, there was a very high prevalence of cardiovascular 238 risk factors. Nevertheless, only one patient had a relevant atherosclerotic lesion at the 239 thrombus attachment site confirmed by CT, whereas in all other patients, the aortic wall 240 appeared normal or with minimal calcifications on CT scans. Histological examination of 241 the attachment sites resected along with the thrombus, showed a cholesterol-rich 242 plaque in three out of four patients. These findings suggest that atherosclerosis does 243 
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contribute to the pathogenesis of floating aortic thrombi, but may not be apparent as 244 calcified plaque. The degree of atherosclerotic contribution may differ between patients 245 and other factors, like haematological abnormalities and steroid treatment may 246 additionally facilitate thrombus formation. 247 TEE is considered the technique of choice to detect and characterise thoracic aortic 248 lesions like intramural haemorrhage, dissection and atherosclerosis (18, 19). However, 249 visualisation of a short segment of the most cranial ascending aorta proximally to the 250 origin of the innominate artery is limited in TEE (18). In our series, one patient 251 underwent two TEE examinations with no pathological findings before aortic arch 252 thrombus was diagnosed by CT. Therefore, especially if no other embolic source is 253 found, diagnostic workup of patients with cerebral, visceral or peripheral emboli should 254 be completed by CT angiography of the whole aorta. Even if a cardiac source of 255 embolism is found, CT angiography should be used liberally to exclude a concomitant 256 aortic embolic source with possible therapeutic consequences. 257 Emboli from floating aortic thrombi may cause relevant morbidity and mortality. In our 258 series, one patient suffered from acute Leriche syndrome with complete paraplegia, one 259 had intestinal ischaemia and two suffered from extensive ischaemic strokes with one 260 patient dying from the immediate sequelae. Only two patients (# 4 and 9) were initially 261 asymptomatic. As diagnosis of floating aortic thrombus is usually made after an embolic 262 event, there are very few published reports including asymptomatic patients (12, 20, 263 21). Therefore, little is known about the risk of these patients to suffer from a first-time 264 embolic event, with or without anticoagulation. In a previous autopsy study, 17% of 265 patients with a thrombus in the thoracic or abdominal aorta had evidence of distal 266 embolisation while 6 % had evidence of a major embolic event that was considered the 267 cause of death (2). 268 
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In primarily symptomatic patients, a previous study reported recurrent embolism in 269 four out of twenty-three patients with floating arch thrombus despite intravenous 270 heparin therapy (1). In a systematic review including 200 patients with aortic mural 271 thrombus in all locations, three important predictors of recurrent arterial embolisation 272 were identified: thrombus location in the ascending aorta or arch, mild atherosclerosis 273 of the aortic wall and stroke as a presenting symptom (3). In our series, six out of eight 274 patients who presented with an embolic event had radiological evidence or a history of 275 previous, possibly embolic events and one patient had a another clinically evident 276 embolism (limb ischaemia) before aortic arch thrombus was removed (Table 2). We 277 considered these findings as indicators of a high risk of further recurrence and thus, 278 these patients were treated surgically if no relevant contraindications were present.  279 In our series, no postoperative complications after aortic arch thrombectomy were 280 documented. DHCA time was short and intraoperative TEE monitoring provided 281 additional assurance that thrombotic material did not dislocate during manipulations on 282 the aortic arch or cannulation. Thrombus dislocation would have immediately been 283 detected and would have prompted CT angiography for localisation and subsequent 284 treatment of the embolus with no delay. Although the risk of aortic arch surgery, 285 especially cerebral embolisation, cannot be denied, we believe that with necessary 286 precautions and adequate patient selection, aortic arch thrombectomy can be performed 287 with a high degree of safety as well as efficiency regarding prevention of further embolic 288 events. Floating aortic arch thrombus should therefore be distinguished from aortic arch 289 atheroma or debris, the latter carrying a much higher perioperative risk if surgically 290 removed (15). 291 Patient # 9, treated by anticoagulation, suffered from ischaemic stroke two days after 292 anticoagulation was initiated. It remains unclear, if this was a coincidence. It has been 293 
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postulated before that anticoagulation could possibly trigger further embolic events by 294 lysing the thrombus at a thin attachment site before lysing the thrombus itself. (9). 295 However, it has to be considered that this patient had underlying malignant disease and 296 therefore comparison to patients without malignancy is difficult. 297 Patient # 4, in whom anticoagulation was stopped after the thrombus resolved, later 298 suffered from an embolic event while no recurrent aortic thrombus or other embolic 299 source was found. The cause of this embolism remains unclear. It may be hypothesised 300 that a new thrombus had formed at the old attachment site and embolised entirely. 301 Local recurrence of a thrombus at the same site has been described in another series 302 before (1). In surgically treated patients, resection of the attachment site along with the 303 thrombus should be considered. Resection of the attachment site was not associated 304 with any complications in our series. 305 Procoagulant abnormalities seem to be prevalent in patients with floating aortic 306 thrombi, which emphasises the importance of haematologic workup. However, there are 307 no available recommendations on anticoagulation and antiplatelet therapy in patients 308 with floating aortic thrombus. As atherosclerotic processes may contribute to the 309 pathogenesis of floating aortic thrombi, secondary cardiovascular prevention including 310 lifelong ASA as well as a statin is probably indicated in all patients, but there is no 311 evidence. 312 The main limitation of this study is its retrospective character. As floating aortic arch 313 thrombus is rare, there was no standard protocol in our clinic for such patients and 314 testing for procoagulant abnormalities was not performed routinely. Asymptomatic 315 patients with floating aortic arch thrombus may be underrepresented in this study, as 316 they are less likely referred to our service. 317 
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In conclusion, floating aortic arch thrombus is an under-recognised but dangerous 318 source of cerebral, visceral and peripheral emboli and may cause significant morbidity 319 and mortality. Especially if no other source of emboli is found, diagnostic workup of 320 patients with systemic emboli by CT angiography is mandatory. Symptomatic patients 321 with floating aortic arch thrombus should be considered at high risk for recurrent 322 embolism and we therefore advocate open thrombus removal with resection of the 323 attachment site. Conservative treatment with anticoagulation only may be considered in 324 selected cases, e.g. high-risk and older patients with contraindications for surgery as 325 well as in asymptomatic patients.  326 
 18 
Figure legends 327 
 328 
Central Picture: Floating aortic arch thrombus. 329 
Figure 1: Computed tomography images of floating aortic arch thrombus (patient # 7). 330 
Figure 2: Attachment sites of 13 thrombi in 10 patients (two concurrent thrombi in 331 three patients). 332 
Figure 3: Intraoperative images (patient # 5): View into the proximal aortic arch. The 333 thrombus is removed by means of a dissector (left). The aortic wall at the attachment 334 site is fixed with a thread and completely cut out (right). 335 
Video: Removal of floating thrombus in the proximal aortic arch.  336 
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